dendritic cell-autologous lung tumor vaccine
Semantic Scholar uses AI to extract papers important to this topic.
BackgroundStandard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the… Expand Background The survival rate in recurrent Glioblastoma multiforme (rGBM) patients has not meaningfully changed in the past… Expand Background Recurrent glioblastoma multiforme (rGBM) is a life threatening condition, with a mortality rate of approximately 100… Expand Dendritic cells (DC) are acknowledged to be quintessential in the armamentarium to mount anti-tumor immune responses and have… Expand Background: DCVax®-Brain (Northwest Biotherapeutics, Inc., Bethesda, MD, USA) is a personalized treatment for brain tumors. Its… Expand